On Friday, RAPT Therapeutics Inc (NASDAQ: RAPT) opened at On Friday, higher 14.71% from the last session, before settling in for the closing price of $1.02. Price fluctuations for RAPT have ranged from $0.71 to $4.21 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 87.68% at the time writing. With a float of $68.99 million, this company’s outstanding shares have now reached $132.01 million.
The extent of productivity of a business whose workforce counts for 68 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
RAPT Therapeutics Inc (RAPT) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of RAPT Therapeutics Inc is 47.85%, while institutional ownership is 51.92%.
RAPT Therapeutics Inc (RAPT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 87.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 48.05% during the next five years compared to -10.10% drop over the previous five years of trading.
RAPT Therapeutics Inc (NASDAQ: RAPT) Trading Performance Indicators
Check out the current performance indicators for RAPT Therapeutics Inc (RAPT). In the past quarter, the stock posted a quick ratio of 21.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.41, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.50 in one year’s time.
Technical Analysis of RAPT Therapeutics Inc (RAPT)
The latest stats from [RAPT Therapeutics Inc, RAPT] show that its last 5-days average volume of 0.6 million was inferior to 0.9 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 54.53%. Additionally, its Average True Range was 0.12.
During the past 100 days, RAPT Therapeutics Inc’s (RAPT) raw stochastic average was set at 53.59%, which indicates a significant decrease from 78.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 204.61% in the past 14 days, which was higher than the 113.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9412, while its 200-day Moving Average is $1.3874. Now, the first resistance to watch is $1.2200. This is followed by the second major resistance level at $1.2700. The third major resistance level sits at $1.3400. If the price goes on to break the first support level at $1.1000, it is likely to go to the next support level at $1.0300. The third support level lies at $0.9800 if the price breaches the second support level.
RAPT Therapeutics Inc (NASDAQ: RAPT) Key Stats
There are currently 132,289K shares outstanding in the company with a market cap of 154.78 million. Presently, the company’s annual sales total 0 K according to its annual income of -129,870 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -17,170 K.
